Dr Juanita Lopez is listed as a consultant within The Royal Marsden's Drug Development Unit in London. The unit specialises in Phase I cancer drug trials and forms part of the hospital's specialist clinical research infrastructure.

Her role is associated with medical oncology and early-phase clinical research. Cancer drug development involves carefully designed studies intended to assess new therapies, combinations and approaches to treatment. Early-phase trials commonly focus on safety, tolerability, dosing and initial evidence of therapeutic activity.

The Royal Marsden's specialist research environment brings together consultants, research nurses, laboratory staff, study managers and other professionals. This multidisciplinary structure supports patients throughout the clinical-trial process and ensures that research is conducted according to the requirements of individual protocols.

For patients searching for cancer specialists in London, Dr Lopez's profile may be particularly relevant to those interested in medical oncology and clinical research. However, being associated with a clinical-trial unit does not mean that every trial is suitable for every patient. Each study has its own inclusion and exclusion criteria.

Patients considering an early-phase study may undergo detailed assessment before enrolment. The assessment can include review of pathology, imaging, previous treatments, laboratory results and other clinical information. The research team then determines whether the patient meets the specific requirements of the available protocol.

International patients should also consider referral procedures and the need to provide complete medical records. Information such as pathology reports, diagnostic imaging and previous treatment details can help specialist teams assess the patient's circumstances.

The Royal Marsden's recent Drug Development Unit information identifies Dr Juanita Lopez among its consultants, alongside Professor Johann de Bono, Professor Udai Banerji, Dr Anna Minchom, Dr Adam Sharp and Dr Alec Paschalis.

For SEO and medical-directory purposes, Dr Lopez's profile can focus on medical oncology, cancer clinical trials, early-phase research and cancer drug development. These terms accurately reflect the clinical research setting in which she is listed.

Patients should obtain current information directly from The Royal Marsden about available trials, consultant appointments, referral requirements and eligibility. Clinical-trial programmes can change as studies open, recruit participants, close recruitment or complete.

A specialist oncology consultation remains important because treatment decisions depend on the patient's diagnosis, cancer stage, previous treatment, molecular findings and overall clinical circumstances. Online information should supplement rather than replace professional medical assessment.